HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review.

Abstract
The surgical guidelines for male breast cancer (MBC) have been largely guided by female-predominant clinical trials. Because no clinical trial has been conducted to examine the surgical treatment of MBC, we performed a systematic review comparing the survival of patients with MBC who had undergone breast conserving surgery (BCS) and those who had undergone mastectomy and evaluated the patients' radiotherapy compliance after BCS. We performed a systematic search of electronic databases to find MBC cohort studies that had reported ≥ 1 survival outcome (disease-free survival [DFS], disease-specific survival [DSS], or overall survival [OS]) stratified by surgical treatment (BCS and/or mastectomy) and/or radiotherapy compliance with BCS. A total of 1 prospective and 9 retrospective cohort studies were included, with the number of patients ranging from 7 to 6039. Of the BCS patients, compliance with postoperative radiotherapy was low (range, 27%-46%), with the exception of 1 single-institution prospective study that reported 86% compliance (6 of 7 patients). The pooled estimate for all patients with MBC was 83% (95% confidence interval [CI], 78%-88%) for 5-year DSS and 66% (95% CI, 63%-70%) for 5-year OS. Most studies reported no differences in DFS, DSS, or OS for BCS and mastectomy. BCS is a reasonable treatment approach for MBC because it was associated with oncologic outcomes similar to those with mastectomy. However, the low rates of radiotherapy compliance among male patients who underwent BCS is concerning and highlights the importance of shared decision-making with patients with MBC when selecting a surgical treatment strategy.
AuthorsCandice A M Sauder, Sarah B Bateni, Anders J Davidson, Daniel K Nishijima
JournalClinical breast cancer (Clin Breast Cancer) Vol. 20 Issue 3 Pg. e309-e314 (06 2020) ISSN: 1938-0666 [Electronic] United States
PMID32171701 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S., Systematic Review)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Topics
  • Breast Neoplasms, Male (mortality, therapy)
  • Clinical Decision-Making
  • Decision Making, Shared
  • Disease-Free Survival
  • Humans
  • Male
  • Mastectomy, Segmental (statistics & numerical data)
  • Neoplasm Recurrence, Local (epidemiology, prevention & control)
  • Patient Compliance (statistics & numerical data)
  • Prospective Studies
  • Radiotherapy, Adjuvant (statistics & numerical data)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: